Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
EXACT Sciences Corporation Stock Forecast NASDAQ:EXAS
Price Target and Analyst Ratings
Most Recent Rating
On Nov 03, 2021 "SVB Leerink" gave "$160.00 - $140.00" rating for EXAS. The price target was changed from $92.86 to 2.9%.
Last 30 Days
Historical Ratings
| Date | Rating | Action | Authority | Current Price | Target Price |
|---|---|---|---|---|---|
| 2021-11-03 | $160.00 - $140.00 | Target Lowered by | SVB Leerink | $94.32 | $92.86→2.9% |
| 2021-11-03 | $120.00 - $95.00 | Target Lowered by | Wells Fargo & Company | $94.32 | $92.86→2.9% |
| 2021-11-03 | $125.00 - $116.00 | Target Lowered by | Robert W. Baird | $94.32 | $92.86→2.9% |
| 2021-11-03 | $160.00 - $130.00 | Downgraded by | Raymond James | $94.32 | $92.86→2.9% |
| 2021-11-03 | $144.00 - $133.00 | Target Lowered by | Craig Hallum | $94.32 | $92.86→2.9% |
| 2021-11-03 | $145.00 - $120.00 | Target Lowered by | BTIG Research | $94.32 | $92.86→2.9% |
| 2021-10-14 | $160.00 - $135.00 | Target Lowered by | Cowen | $97.75 | $97.75+0.4% |
| 2021-07-29 | $155.00 - $145.00 | Reiterated by | BTIG Research | $111.91 | $112.36→3.2% |
| 2021-07-29 | $157.00 - $127.00 | Target Lowered by | Robert W. Baird | $111.91 | $116.06+3.7% |
| 2021-07-29 | $185.00 - $160.00 | Target Lowered by | Canaccord Genuity | $111.91 | $116.06+3.7% |
| 2021-07-29 | $161.00 - $155.00 | Target Lowered by | Oppenheimer | $111.91 | $116.06+3.7% |
| 2021-07-29 | $155.00 - $145.00 | Target Lowered by | BTIG Research | $111.91 | $116.06+3.7% |
| 2021-07-29 | $165.00 - $145.00 | Target Lowered by | Stifel Nicolaus | $111.91 | $116.06+3.7% |
| 2021-07-14 | $170.00 - $160.00 | Target Lowered by | SVB Leerink | $110.54 | $114.48→1.5% |
| 2021-06-21 | Equal Weight | Target Raised by | Wells Fargo & Company | $127.66 | $115.00 → $120.00 |
| 2021-06-15 | Strong-Buy | Initiated by | Raymond James | $122.57 | |
| 2021-06-15 | Strong-Buy | Initiated by | Raymond James | $122.57 | $160.00 |
| 2021-06-03 | Buy | Initiated by | The Goldman Sachs Group | $107.91 | $160.00 |
| 2021-05-25 | Equal Weight | Initiated by | Wells Fargo & Company | $109.88 | $115.00 |
| 2021-05-18 | Buy | Target Lowered by | Truist Securities | $96.58 | $226.00 → $168.00 |
| 2021-05-12 | Buy | Target Lowered by | Truist Securities | $96.11 | $226.00 → $168.00 |
| 2021-05-12 | Target Lowered by | Truist | $96.11 | $226.00 → $168.00 | |
| 2021-05-11 | Outperform | Target Lowered by | SVB Leerink | $98.00 | $180.00 → $170.00 |
| 2021-05-05 | Buy | Target Lowered by | BTIG Research | $110.65 | $175.00 → $155.00 |
| 2021-05-05 | Outperform | Target Lowered by | SVB Leerink | $110.65 | $180.00 → $170.00 |
| 2021-05-05 | Buy | Target Lowered by | Craig Hallum | $110.65 | $161.00 → $144.00 |
| 2021-02-18 | Outperform | Target Lowered by | Robert W. Baird | $141.65 | $169.00 → $163.00 |
| 2021-02-17 | Market Perform - Outperform | Target Raised by | SVB Leerink | $140.99 | $170.00 → $180.00 |
| 2021-02-17 | Outperform | Target Raised by | Cowen | $140.99 | $154.00 → $180.00 |
| 2021-02-17 | Buy | Target Raised by | Stifel Nicolaus | $140.99 | $150.00 → $165.00 |
| 2021-01-27 | Buy | Initiated by | Truist | $136.85 | |
| 2021-01-27 | Buy | Initiated by | Truist | $136.85 | $226.00 |
| 2021-01-21 | Outperform | Target Raised by | SVB Leerink | $148.07 | $160.00 → $170.00 |
| 2021-01-12 | Buy | Target Raised by | Canaccord Genuity | $148.42 | $160.00 → $165.00 |
| 2020-10-29 | Buy - Neutral | Downgraded by | UBS Group | $120.51 | $125.00 → $140.00 |
| 2020-10-28 | Buy - Neutral | Downgraded by | Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell | $127.52 | $120.00 → $140.00 |
| 2020-10-28 | Buy | Target Raised by | Benchmark | $127.52 | $110.00 → $145.00 |
| 2020-10-28 | Positive - Outperform | Target Raised by | Robert W. Baird | $127.52 | $135.00 → $150.00 |
| 2020-10-28 | Outperform | Target Raised by | SVB Leerink | $127.52 | $115.00 → $160.00 |
| 2020-10-28 | Buy - Neutral | Downgraded by | Smith Barney Citigroup | $127.52 | $120.00 → $140.00 |
| 2020-10-28 | Target Raised by | BTIG Research | $127.52 | $140.00 → $155.00 | |
| 2020-10-28 | Target Raised by | Oppenheimer | $127.52 | $115.00 → $150.00 | |
| 2020-10-28 | Buy | Target Raised by | Canaccord Genuity | $127.52 | $120.00 → $145.00 |
| 2020-09-25 | Buy | Target Raised by | Canaccord Genuity | $97.70 | $115.00 → $120.00 |
| 2020-07-31 | Outperform | Target Raised by | SVB Leerink | $94.75 | $90.00 → $115.00 |
| 2020-07-31 | Buy | Target Raised by | Citigroup | $94.75 | $110.00 → $120.00 |
| 2020-07-31 | Buy | Target Raised by | Benchmark | $94.75 | $90.00 → $110.00 |
| 2020-07-08 | Buy | Reiterated by | Oppenheimer | $91.66 | |
| 2020-06-25 | Buy | Target Raised by | Citigroup | $83.88 | $100.00 → $110.00 |
| 2020-05-07 | Buy | Target Lowered by | Canaccord Genuity | $82.85 | $120.00 → $110.00 |
| 2020-05-07 | Outperform | Target Lowered by | SVB Leerink | $82.85 | $100.00 → $90.00 |
| 2020-05-07 | In-Line - Buy | Target Lowered by | Craig Hallum | $82.85 | $99.00 → $92.00 |
| 2020-05-07 | Buy | Target Raised by | Bank of America | $82.85 | $88.00 → $94.00 |
| 2020-05-07 | Outperform | Target Raised by | Robert W. Baird | $82.85 | $90.00 → $92.00 |
| 2020-04-28 | Buy | Target Lowered by | UBS Group | $77.17 | $135.00 → $115.00 |
| 2020-04-22 | Outperform | Target Lowered by | Robert W. Baird | $74.05 | $100.00 → $90.00 |
| 2020-04-22 | Buy | Target Lowered by | Citigroup | $74.05 | $120.00 → $100.00 |
| 2020-04-21 | Buy | Reiterated by | Oppenheimer | $76.51 | $115.00 |
| 2020-04-17 | Buy | Target Lowered by | Craig Hallum | $74.65 | $127.00 → $99.00 |
EXAS Stock Trend
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -16.57% during the next 3 months and, with a 90% probability hold a price between $63.16 and $78.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2021-12-10 | $75.40 | $84.63 | $93.85 |
| 2021-12-13 | $75.11 | $84.33 | $93.56 |
| 2021-12-14 | $74.81 | $84.04 | $93.26 |
| 2021-12-15 | $74.51 | $83.74 | $92.96 |
| 2021-12-16 | $74.22 | $83.44 | $92.67 |
| 2021-12-17 | $73.92 | $83.15 | $92.37 |
| 2021-12-20 | $73.62 | $82.85 | $92.07 |
| 2021-12-21 | $73.33 | $82.55 | $91.78 |
| 2021-12-22 | $73.03 | $82.26 | $91.48 |
| 2021-12-23 | $72.73 | $81.96 | $91.18 |
| 2021-12-27 | $72.44 | $81.66 | $90.89 |
| 2021-12-28 | $72.14 | $81.36 | $90.59 |
| 2021-12-29 | $71.84 | $81.07 | $90.29 |
| 2021-12-30 | $71.55 | $80.77 | $90.00 |
| 2021-12-31 | $71.25 | $80.47 | $89.70 |
| 2022-01-03 | $70.95 | $80.18 | $89.40 |
| 2022-01-04 | $70.66 | $79.88 | $89.11 |
| 2022-01-05 | $70.36 | $79.58 | $88.81 |
| 2022-01-06 | $70.06 | $79.29 | $88.51 |
| 2022-01-07 | $69.76 | $78.99 | $88.22 |
| 2022-01-10 | $69.47 | $78.69 | $87.92 |
| 2022-01-11 | $69.17 | $78.40 | $87.62 |
| 2022-01-12 | $68.87 | $78.10 | $87.33 |
| 2022-01-13 | $68.58 | $77.80 | $87.03 |
| 2022-01-14 | $68.28 | $77.51 | $86.73 |
| 2022-01-17 | $67.98 | $77.21 | $86.44 |
| 2022-01-18 | $67.69 | $76.91 | $86.14 |
| 2022-01-19 | $67.39 | $76.62 | $85.84 |
| 2022-01-20 | $67.09 | $76.32 | $85.55 |
| 2022-01-21 | $66.80 | $76.02 | $85.25 |
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. Its Cologuard test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company has a collabor... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
